Results 231 to 240 of about 49,811 (292)

GLP‐1 Receptor Agonists in Metabolic Dysfunction‐Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes

open access: yesChronic Diseases and Translational Medicine, Volume 12, Issue 2, Page 85-99, June 2026.
Endogenous GLP‐1 and exogenous GLP‐1 RAs activate GLP‐1R‐expressing vagal afferents in the portal vein, projecting to the nucleus tractus solitarius (NTS). This input engages brainstem–hypothalamic circuits that regulate metabolic homeostasis. Hypothalamic efferent vagal output to the liver suppresses lipogenesis, enhances triglyceride export, and ...
Gabriel Amorim Moreira Alves   +8 more
wiley   +1 more source

Pancreatic Islet Cell Crosstalk: Insight Into α‐/β‐Cell Compensatory Mechanisms

open access: yesComprehensive Physiology, Volume 16, Issue 3, June 2026.
α‐cell remodeling compensates for impaired β‐cell function. Intra‐islet glucagon/GLP‐1 signaling is upregulated and becomes essential in prediabetic islets. Flexible receptor engagement reflects functional plasticity in hormonal control of insulin secretion. Created in BioRender. Plecita, L. (2026); https://BioRender.com/pgjjg3m.
Štěpánka Benáková   +5 more
wiley   +1 more source

Long‐term trends in metabolic profiles across Chinese birth cohorts: A real‐world big data analysis

open access: yesClinical and Translational Medicine, Volume 16, Issue 6, June 2026.
• Younger generations (1980s–1990s) exhibit higher fasting glucose and rebounding total cholesterol and low‐density lipoprotein cholesterol, alongside declining high‐density lipoprotein cholesterol and triglycerides compared to 1930s–1970s cohorts.
Ying Xiong   +7 more
wiley   +1 more source

Nutraceutical Evaluation of Biscuits Formulated From Acha, Chia, and Soycake Flours on Glycemic Control, Lipid Profile, and Histopathological Effects in High‐Fat Diet/Streptozotocin‐Induced Type 2 Diabetic Rats

open access: yesFood Chemistry International, Volume 2, Issue 2, Page 164-174, June 2026.
Acha–chia–soycake biscuits improved glucose tolerance, lipid profile, insulin levels, and pancreatic integrity in HFD–STZ diabetic rats. ACSB1 and ACSB13 outperformed acarbose, showing potent antihyperglycemic, hypolipidemic, and pancreatic‐protective effects.
Oluwafunmilayo Christianah Ogunnowo   +5 more
wiley   +1 more source

Correlation Between Dietary Index for Gut Microbiota With All‐Cause and Cardiovascular Mortality in Cardiovascular‐Kidney‐Metabolic Syndrome Patients

open access: yesFood Science &Nutrition, Volume 14, Issue 6, June 2026.
This study first demonstrates that in CKM syndrome patients, a higher dietary index for gut microbiota (DI‐GM) is associated with lower all‐cause and cardiovascular mortality. Each 1‐point increase in DI‐GM reduces all‐cause mortality risk by 10% and cardiovascular mortality by 12%.
Anwu Huang   +4 more
wiley   +1 more source

Cardiometabolic Risk and Structural Brain Development in a Large Community‐Based US Cohort

open access: yesHuman Brain Mapping, Volume 47, Issue 8, June 1, 2026.
In a large longitudinal cohort of US youth, cardiometabolic risk factors showed predominantly null associations with global brain structure across adolescence. Aside from modest links between higher BMI and thinner cortex, and higher resting heart rate and white matter microstructure, cardiometabolic variation did not track within‐person brain change ...
Dani Beck   +2 more
wiley   +1 more source

The Association Between Fibrosis‐4 Index and All‐Cause and Cardiac Mortality in Patients With Coronary Heart Disease Combined With Diabetes or Prediabetes: Findings From Two Large‐Scale Prospective Cohort Studies

open access: yesMedComm, Volume 7, Issue 6, June 2026.
The current study used two large‐scale cohorts to investigate the association between FIB‐4 index and all‐cause and cardiac‐mortality risk. Elevated FIB‐4, both as categorical and continuous variable, was associated with increased risk of all‐cause and cardiac‐mortality. ABSTRACT Determining the link between fibrosis‐4 index (FIB‐4) score, which serves
Chenxi Song   +11 more
wiley   +1 more source

Beyond the Known and Established Neurodegenerative Effects: Roles of APOE Across a Wide Spectrum of Pathophysiological Condition

open access: yesMedComm, Volume 7, Issue 6, June 2026.
APOE is widely recognized for its role in neurodegeneration and cardiovascular disease, but its different genotypes also influence body composition, affecting obesity, bone density, and muscle mass, through their central role in lipid transport and metabolism.
Miriam Frosina   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy